What the study found
People with advanced Parkinson’s disease and their care partners placed the most importance on route of administration and on time without troublesome dyskinesia, which means hours spent “ON” with motor benefit but without troublesome involuntary movements. Oral pills were the most preferred option, followed by a non-surgical infusion device, such as subcutaneous infusion.
Why the authors say this matters
The authors conclude that understanding these preferences may help healthcare providers and people with advanced Parkinson’s disease make more informed and meaningful treatment decisions. The study suggests that treatment choices should account for both symptom control and how the treatment is delivered.
What the researchers tested
The researchers surveyed 304 participants from the USA, UK, and Germany, including 223 people with advanced Parkinson’s disease and 81 care partners. They used a discrete choice experiment, a survey method that asks people to choose between hypothetical treatment options described by seven features: hours of ON time without troublesome dyskinesia, early morning OFF time, skin reaction risk, risk of severe side effects requiring hospitalization, route of administration, pill regimen frequency, and device maintenance frequency.
What worked and what didn't
In the survey design, route of administration had the highest conditional relative importance, followed by hours of ON time without troublesome dyskinesia. The other attributes were of similar importance. Nonsurgical treatments were strongly preferred, with oral pills ranked highest and subcutaneous infusion next.
What to keep in mind
The abstract does not describe limitations in detail. The results reflect preferences measured in a survey of hypothetical treatment choices, not actual treatment outcomes.
Key points
- Among survey attributes, route of administration was the most important for participants.
- Hours of ON time without troublesome dyskinesia was the second most important attribute.
- Oral pills were the most preferred treatment option.
- A non-surgical infusion device, including subcutaneous infusion, was preferred next.
- The study included 304 participants from the USA, UK, and Germany.
Disclosure
- Research title:
- Advanced Parkinson’s patients prioritized treatment route and ON time
- Publication date:
- 2026-04-02
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.

